EUVIMEDEUVIMED entdecken
Multizentrische Studie

TP53 co-mutations increase risk of recurrence in EGFR-mutated stage I lung adenocarcinoma

Filippo Tommaso Gallina, Daniele Marinelli, Riccardo Tajè, Paolo Visca, Fabiana Letizia Cecere, Lorenza Landi, Simonetta Buglioni, Daniele Forcella, Enrico Melis, Sara Najmeh, Roni Rayes, Jonathan Cools-Lartigue und 5 weitere

European Journal of Cancer · 2025

DOI: 10.1016/j.ejca.2025.115622 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift European Journal of Cancer, 2025. Verfasst von Filippo Tommaso Gallina und 16 weiteren Autor:innen. Beteiligte Einrichtung: Division of Thoracic Surgery, McGill University Health Centre, Montreal, QC, Canada; Thoracic Surgery Unit, IRCCS "Regina Elena" National Cancer Inst…. Hauptthemen laut MEDLINE: Tumor Suppressor Protein p53, Mutation, Lung Neoplasms, Neoplasm Recurrence, Local. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 32 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tumor Suppressor Protein p53MutationLung NeoplasmsNeoplasm Recurrence, LocalAdenocarcinoma of LungHumansMaleFemaleErbB ReceptorsMiddle AgedAgedNeoplasm StagingPrognosisRetrospective StudiesRisk Factors

Stichwörter der Autor:innen

EGFREarly stageNSCLCStage ITP53

Substanzen

Tumor Suppressor Protein p53ErbB ReceptorsEGFR protein, humanTP53 protein, human

Autor:innen und Institutionen

  • Division of Thoracic Surgery, McGill University Health Centre, Montreal, QC, Canada; Thoracic Surgery Unit, IRCCS "Regina Elena" National Cancer Institute, Rome, Italy; Tumor Immunology and Immunotherapy Unit, IRCCS "Re…
  • Department of Experimental Medicine, Sapienza University, Rome, Italy; Division of Medical Oncology 2, IRCCS "Regina Elena" National Cancer Institute, Rome, Italy.
  • Thoracic Surgery Unit, IRCCS "Regina Elena" National Cancer Institute, Rome, Italy.
  • Pathology Unit, IRCCS "Regina Elena" National Cancer Institute, Rome, Italy.
  • Division of Medical Oncology 2, IRCCS "Regina Elena" National Cancer Institute, Rome, Italy.
  • Division of Thoracic Surgery, McGill University Health Centre, Montreal, QC, Canada.

Zitieren

APA

Gallina, F. T., Marinelli, D., Tajè, R., Visca, P., Cecere, F. L., Landi, L., Buglioni, S., Forcella, D., Melis, E., Najmeh, S., Rayes, R., Cools-Lartigue, J., Camilleri-Broët, S., Fiset, P. O., Ferri, L., Cappuzzo, F., & Spicer, J. (2025). TP53 co-mutations increase risk of recurrence in EGFR-mutated stage I lung adenocarcinoma. European Journal of Cancer. https://doi.org/10.1016/j.ejca.2025.115622

Vancouver

Gallina FT, Marinelli D, Tajè R, Visca P, Cecere FL, Landi L, et al. TP53 co-mutations increase risk of recurrence in EGFR-mutated stage I lung adenocarcinoma. European Journal of Cancer. 2025. doi:10.1016/j.ejca.2025.115622

BibTeX
@article{Gallina2025,
  author = {Gallina, Filippo Tommaso and Marinelli, Daniele and Tajè, Riccardo and Visca, Paolo and Cecere, Fabiana Letizia and Landi, Lorenza and Buglioni, Simonetta and Forcella, Daniele and Melis, Enrico and Najmeh, Sara and Rayes, Roni and Cools-Lartigue, Jonathan and Camilleri-Broët, Sophie and Fiset, Pierre-Olivier and Ferri, Lorenzo and Cappuzzo, Federico and Spicer, Jonathan},
  title = {TP53 co-mutations increase risk of recurrence in EGFR-mutated stage I lung adenocarcinoma},
  journal = {European Journal of Cancer},
  year = {2025},
  doi = {10.1016/j.ejca.2025.115622}
}
Kostenlos starten →